Atorvastatin, 10mg, 20mg, 40mg

DRUG2 trials

Sponsors

The Catholic University of Korea, HealthBio, Inc.

Conditions

Diabetes Mellitus, HypercholessterolemiaLong COVID

Phase 2

A Multi-Center, Individually-Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Superiority Trial to Evaluate the Efficacy of the Combination of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID

Not yet recruitingNCT06974084

HealthBio, Inc.Long COVID

Start: 2026-07-15End: 2027-05-01Target: 252Updated: 2026-06-18

Phase 4

Korean AMADEUS Study

The Catholic University of KoreaDiabetes Mellitus, Hypercholessterolemia

Start: 2009-02-28End: 2011-02-28Target: 500Updated: 2010-11-15

Related Papers

Effects of patient-tailored atorvastatin therapy on ameliorating the levels of atherogenic lipids and inflammation beyond lowering low-density lipoprotein cholesterol in patients with type 2 diabetes.

2013-03-269 citations